The condition can gradually worsen over time, leading to symptoms such as light sensitivity, blurred vision, and partial or complete eyelid closure, and in certain cases, facial muscles can be involved
[4] Veronese, N., Stubbs, B., Solmi, M., Ajnakina, O., Carvalho, A
However, curcumin suffers from extremely poor bioavailability
Wegovy (semaglutide injection) received FDA approval in June 2021 for chronic weight management in adults with obesity (body mass index 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbid condition such as hypertension, type 2 diabetes, or dyslipidemia
Researchers studying metabolic syndrome, NAFLD, and obesity have noted these downstream effects as particularly significant for the differentiation between the two compounds